Programme 2025

Day 1: Thursday 13:00 – 17:30

13:00 – 13:10

Welcome and Introduction

Giuseppe Luigi Banna (UK) & Ravindran Kanesvaran (Singapore)

Prostate (1h)

Chair: Ravindran Kanesvaran (Singapore) Discussant: Elena Castro (Spain)

13:10 – 13:30

Toward precision oncology

Neeraj Agarwal (USA)

13:30 – 13:50

Theragnostic revolution

Partha S. Choudhury (India)

13:50 – 14:10

Translating trial endpoints into clinically meaningful decisions

Alison Tree (UK)

14:10 – 14:50

Industry Symposia 4th September – View List

Symposia are organised and fully funded by pharma companies. Click “View list” for further info.

14:50 – 15:20

Coffee Break (30′)

Rare & GU other matters (1h 10′)

Chair: Giuseppe L. Banna (UK) Discussant: Simon Crabb (UK)

15:20 – 15:40

Minimising toxicity in testicular cancer

Pasquale Rescigno (UK)

15:40 – 16:10

Treatment breaks in GU Cancer: Is it safe?

Renal

Sara Elena Rebuzzi (Italy)

Bladder

Simon Crabb (UK)

16:10 – 16:30

MDTs: Gold Standard or Bottleneck in Urological Cancer Care?

Ben Lamb (UK)

Poster Awards (30′)

Chair: Ravindran Kanesvaran (Singapore) Discussant: Matteo Santoni (Italy)

16:30 – 16:45

Poster Award

TBD

16:45 – 17:00

Selected poster discussion

Aruni Ghose (UK)

17:00 – 17:30

ePoster sessions (30′)

Day 2: Friday 09:00 – 13:10

09:00 – 09:10

Introduction

Bladder (1h)

Chair: Ravindran Kanesvaran (Singapore) Discussant: Param Mariappan (UK)

09:10 – 09:30

How perioperative treatment is evolving

Petros Grivas (USA)

09:30 – 09:50

Getting more patients to the right 1st line of treatment

Enrique Grande (Spain)

09:50 – 10:10

Histology subtypes in bladder cancer; have they been left behind

Stefanie Zschäbitz (Germany)

10:10 – 10:50

Industry Symposia 5th September – View List